Natural Capsules LtdPharmaceuticalsINE936B01015Consolidated₹172.20-3.90 (-2.21%)Jun-26
Valuation
Market Cap₹179.28 Cr
TTM PE-7.17x
Forward PE-7.49x
PEG-11.38
Book Value₹212.89
P/B0.81x
TTM EPS₹-24.01
Fwd EPS₹-23.00
TTM Revenue₹190.71 Cr
TTM PAT₹-24.83 Cr
TTM EBITDA₹-0.77 Cr
TTM EBIT₹-18.03 Cr
Last Qtr PAT₹-5.74 Cr
Last Qtr EBITDA₹1.11 Cr
Last Qtr EBIT₹-3.22 Cr
Profitability
ROE-11.20%
ROCE0.74%
TTM NPM-13.02%
TTM EBITDA %-0.40%
Curr OPM-11.24%
Last OPM-8.41%
Curr NPM
Last NPM
Curr EPS₹-5.55
Last EPS₹-4.82
Balance sheet
Equity₹10.39 Cr
Reserve₹211.25 Cr
Total Debt₹115.47 Cr
D/E0.52x
Interest %-86.59%
Curr Interest₹4.97 Cr
Price / range
Close₹172.20
vs 52W High
vs 52W Low
MA50
MA200
Returns
1D-2.21%
1W-8.65%
1M+16.59%
3M+7.76%
6M+16.12%
1Y-16.02%
2Y-48.49%
3Y-56.26%
5Y+10.92%
Diwali-3.10%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue43.02-2.8%50.8034.1544.5844.24173.77
Other Income2.312.132.111.731.697.65
Total Income45.33-1.3%52.9336.2546.3145.93181.42
Interest1.441.491.451.451.365.75
Expenditure-39.67+6.6%-45.49-35.80-42.61-42.46-166.36
PBDT000000
EBITDA6.89+34.3%8.861.895.445.1321.32
Depreciation-2.10-2.06-2.09-2.02-1.99-8.16
EBIT4.79+52.5%6.80-0.203.423.1413.16
PBT5.66+62.6%7.430.463.703.4815.07
Tax-1.63-1.91-0.10-0.89-0.95-3.85
Equity10.4110.390010.3410.39
OPM12.4914.041.348.307.588.30
Net Profit4.04+60.3%5.520.362.812.5211.21
NPM8.9110.431.066.305.496.18
EPS3.89+59.4%5.330.352.722.4410.79

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue173.77+3.5%167.94+9.2%153.81-11.0%172.87+28.0%135.07+69.9%79.51
Other Income7.654.243.141.070.930.73
Total Income181.42+5.4%172.17+9.7%156.95-9.8%173.94+27.9%136+69.5%80.24
Expenditure-166.36-2.1%-162.88-11.1%-146.56+1.1%-148.20-27.1%-116.57-59.2%-73.23
Interest-5.75-5.91-4.95-3.56-1.96-0.37
PBDT000000
EBITDA21.32+10.5%19.30-7.1%20.77-41.4%35.43+38.9%25.50+132.7%10.96
Depreciation-8.16-8.33-8.57-7.20-5.04-4.31
EBIT13.16+20.0%10.97-10.1%12.20-56.8%28.23+38.0%20.46+207.7%6.65
PBT15.07+62.0%9.30-10.5%10.39-59.6%25.74+32.5%19.43+111.4%9.19
Tax-3.85-2.59-2.59-6.55-5.47-2.24
Equity10.3910.340000
OPM (%)8.305.407.0015.0014.0011.00
Net Profit11.21+67.1%6.71-14.0%7.80-59.4%19.19+37.5%13.96+100.9%6.95
NPM (%)6.183.905.0011.0010.009.00
EPS (Rs)10.79+76.3%6.12-29.2%8.640-100.0%19.62+77.7%11.04
CEPS10.796.128.64019.6211.04

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue48.71+7.8%58.4537.7545.8045.20187.21
Other Income2.350.760.450.160.361.73
Total Income51.06+12.1%59.2238.1945.9645.56188.94
Interest4.972.892.852.682.5310.95
Expenditure-56.90-10.2%-64.29-47.28-53.66-51.63-216.86
PBDT000000
EBITDA1.11+258.1%1.33-2.32-0.890.31-1.57
Depreciation-4.33-4.28-4.36-4.29-4.21-17.14
EBIT-3.22+17.4%-2.95-6.68-5.18-3.90-18.71
PBT-5.83+3.8%-5.0800-6.06-27.92
Tax0.090.101.970.710.483.26
Equity10.4110.390010.3410.39
OPM-11.42-8.580.000.00-13.30-14.78
Net Profit-5.74-2.9%-4.98-7.12-6.99-5.58-24.66
NPM-11.24-8.41-18.63-15.21-12.25-13.05
EPS-5.55-2.8%-4.82-6.88-6.76-5.400

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 21-22FY 20-21FY 19-20
Revenue187.20+10.6%169.21+8.9%155.42135.07+69.9%79.51+29.2%61.56
Other Income1.730.701.941.010.730.95
Total Income188.94+11.2%169.91+8.0%157.36136.08+69.6%80.24+28.4%62.51
Expenditure-216.86-29.8%-167.12-11.9%-149.31-116.69-59.3%-73.26-19.8%-61.14
Interest-10.95-6.31-5.13-1.96-0.37-0.77
PBDT000000
EBITDA-1.57-109.0%17.52-12.0%19.9125.38+132.2%10.93+105.8%5.31
Depreciation-17.14-9.12-8.67-5.04-4.31-4.12
EBIT-18.71-322.7%8.40-25.3%11.2420.34+207.3%6.62+456.3%1.19
PBT-27.92-1100.7%2.79-65.3%8.0519.39+111.7%9.16+568.6%1.37
Tax3.26-2.17-2.50-5.47-2.25-0.51
Equity10.3910.340000
OPM (%)-14.781.645.1214.2511.422.19
Net Profit-24.66-4077.4%0.62-88.8%5.5513.92+101.4%6.91+703.5%0.86
NPM (%)-13.050.363.5310.238.611.38
EPS (Rs)0-100.0%0.22-96.5%6.2319.56+78.0%10.99+679.4%1.41
CEPS00.226.2319.5610.991.41

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

16
YearTypeAmountEx-Date
2023Final Dividend120 Jul 2023
2022Final Dividend109 Sep 2022
2021Final Dividend106 Jul 2021
2020Final Dividend0.612 Aug 2020
2019Final Dividend113 Aug 2019
2018Final Dividend112 Sep 2018
2017Final Dividend118 Aug 2017
2016Final Dividend1.516 Aug 2016
2015Final Dividend1.519 Aug 2015
2014Final Dividend1.520 Aug 2014
2013Final Dividend1.519 Jul 2013
2012Final Dividend1.520 Jul 2012
2011Final Dividend1.221 Jul 2011
2010Final Dividend1.223 Sep 2010
2009Final Dividend1.223 Jul 2009
2008Final Dividend124 Jul 2008

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers